Abstract
Nitric oxide (NO) is generated by a family of isoenzymes (NO synthases) expressed in a wide range of mammalian cells. We have recently reported NO synthase expression in human gynaecological cancers. In this study we have assessed the activity and distribution of NO synthase in a series of human breast tumours and in normal breast tissue. Calcium-dependent (constitutive) and -independent (inducible) NO synthase activity, as well as NO biosynthesis, was high in invasive tumours compared with benign or normal tissue. Furthermore, for invasive ductal carcinomas, NO biosynthesis was significantly greater for grade III compared with grade II tumours. Immunohistochemical investigations revealed immunolabelling with a monoclonal antibody to murine inducible NO synthase predominantly within tumour-associated macrophages. Immunolabelling with a polyclonal antiserum raised against rat brain NO synthase was also observed in vascular endothelial and myoepithelial cells. Thus NO synthase is expressed in human breast tumours, where its presence correlates with tumour grade.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomsen, L., Miles, D., Happerfield, L. et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 72, 41–44 (1995). https://doi.org/10.1038/bjc.1995.274
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.274
This article is cited by
-
A DNA-based fluorescent probe maps NOS3 activity with subcellular spatial resolution
Nature Chemical Biology (2020)
-
Assessment of YKL-40, lipid profile, antioxidant status, and some trace elements in benign and malignant breast proliferation
Molecular Biology Reports (2020)
-
Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ
Scientific Reports (2019)
-
EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment
Journal of Neuroinflammation (2017)
-
Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer
Breast Cancer Research (2017)